Tag: Hatch-Waxman Act

Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.

Explore how the FDA approves generic drugs via the ANDA process, ensuring safety and savings. Learn about bioequivalence standards, GDUFA timelines, and the impact of the Hatch-Waxman Act on your medication.

Recent-posts

Your Ultimate Guide to Buying Prelone Online: Uses, Dosage & Side Effects

Your Ultimate Guide to Buying Prelone Online: Uses, Dosage & Side Effects

Jan, 10 2024

Generic Drug Prices: US vs Europe and Why They Differ

Generic Drug Prices: US vs Europe and Why They Differ

Jul, 3 2026

Border and Customs Rules for Bringing Medications Internationally in 2025

Border and Customs Rules for Bringing Medications Internationally in 2025

Nov, 25 2025

2025 Alternatives for Prelone: A Practical Guide

2025 Alternatives for Prelone: A Practical Guide

Feb, 28 2025

Bioequivalence Studies: How to Meet FDA Requirements for Generic Drug Approval

Bioequivalence Studies: How to Meet FDA Requirements for Generic Drug Approval

Apr, 13 2026